Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): a randomized controlled trial
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003348
- Lead Sponsor
- Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) There is no restrictions on gender and age;
(2) Patients diagnosed with mild pneumonia (slight clinical symptoms, no pneumonia manifestations on imaging), general pneumonia patients (with fever, respiratory tract symptoms, etc., imaging showed pneumonia but no multiple organ damage);
(3) Hospitalized patients;
(4) Volunteer to join the trial and sign the informed consent;
(5) Promise not to perform other exercise activities.
(1) patients with severe diseases such as cardiovascular, cerebrovascular, hematopoietic, digestive system or mental illness;
(2) pregnant and lactating women;
(3) respiratory frequency> 30 times /min, showing respiratory failure;
(4) complicated with other organ failure requires treatment by respiratory intensive care unit (ICU);
(5) those who do not want to join the trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Health Questionnaire;Clinical Respiratory Symptom Scale;Fatigue scale-14;Modify Borg Dyspnea Score;
- Secondary Outcome Measures
Name Time Method